These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22681920)

  • 1. [A meta analysis of radiosensitivity on non-small cell lung cancer by metronidazole amino acidum natrium].
    Ren W; Li Z; Mi D; Yang K; Tian J; Zhang Z
    Zhongguo Fei Ai Za Zhi; 2012 Jun; 15(6):340-7. PubMed ID: 22681920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metronidazole amino acidum natrium combined with radiation in the treatment of nasopharyngeal carcinoma: A meta-analysis based on randomized controlled trials.
    Wei S; Xing Y; Liu J; Wang L; Yang X; Song F; Yang C; Niu L; Yang Y; Wu F
    J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C222-5. PubMed ID: 26506881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A meta analysis of aidi injection plus taxotere and cisplatin in the treatment of non-small cell lung cancer].
    Wang Q; He X; Tian J; Wang X; Ru P; Ruan Z; Yang K
    Zhongguo Fei Ai Za Zhi; 2010 Nov; 13(11):1027-34. PubMed ID: 21081042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
    Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials.
    Xiao Z; Wang CQ; Zhou MH; Li NN; Liu SY; He YJ; Wang YZ; Feng JH; Yao XS; Chen L; Ma B; Yu S; Zeng XT; Li CW; Ding J
    Int Immunopharmacol; 2018 Aug; 61():363-375. PubMed ID: 29945024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive immunotherapy with interleukin-2 & induced killer cells in non-small cell lung cancer: A systematic review & meta-analysis.
    Mi D; Ren W; Yang K
    Indian J Med Res; 2016 May; 143(Supplement):S1-S10. PubMed ID: 27748271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of rh-endostatin combined with chemotherapy versus chemotherapy alone for advanced NSCLC: a meta-analysis review].
    Cao D; Ge W; Wang H; Zhang L; Zheng Y; Zhang J
    Zhongguo Fei Ai Za Zhi; 2011 May; 14(5):404-13. PubMed ID: 21569645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of PD-1/PD-L1 inhibitors combined with radiotherapy in patients with non-small-cell lung cancer: a systematic review and meta-analysis.
    Geng Y; Zhang Q; Feng S; Li C; Wang L; Zhao X; Yang Z; Li Z; Luo H; Liu R; Lu B; Wang X
    Cancer Med; 2021 Feb; 10(4):1222-1239. PubMed ID: 33465302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thermo-chemotherapy of GP or TP for advanced non-small cell lung cancer: a systematic review].
    Mi D; Li Z; Yang K; Cao N; Tian J; Ma B
    Zhongguo Fei Ai Za Zhi; 2012 Aug; 15(8):456-64. PubMed ID: 22901992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of Kanglaite plus EGFR-TKI in the treatment of advanced non-small cell lung cancer: A meta-analysis of 13 RCTs.
    Li D; Li W; Xu L; Che Y; Cheng C
    Medicine (Baltimore); 2022 Dec; 101(50):e32169. PubMed ID: 36550917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and safety of sodium cantharidinate plus chemotherapy in non-small-cell lung cancer: A systematic review and meta-analysis of 38 randomized controlled trials.
    Xiao Z; Wang C; Tan Z; Hu S; Chen Y; Zhou M; Feng J; Liu S; Chen L; Ding J; Gong Q; Tang F; Liu H; Li X
    J Clin Pharm Ther; 2019 Feb; 44(1):23-38. PubMed ID: 30229971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole brain radiotherapy plus concurrent chemotherapy in non-small cell lung cancer patients with brain metastases: a meta-analysis.
    Qin H; Pan F; Li J; Zhang X; Liang H; Ruan Z
    PLoS One; 2014; 9(10):e111475. PubMed ID: 25347291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentinan combined with cisplatin for the treatment of non-small cell lung cancer.
    Zhao C; Yan H; Pang W; Wu T; Kong X; Li X; Liu H; Zhao L; Liang F; Jia Y
    Medicine (Baltimore); 2021 Mar; 100(12):e25220. PubMed ID: 33761711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
    Zhu J; Yuan Y; Wan X; Yin D; Li R; Chen W; Suo C; Song H
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD011300. PubMed ID: 34870327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for advanced non-small cell lung cancer in the elderly population.
    Santos FN; de Castria TB; Cruz MR; Riera R
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010463. PubMed ID: 26482542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Aidi injection alleviate the toxicity and improve the clinical efficacy of radiotherapy in lung cancer?: A meta-analysis of 16 randomized controlled trials following the PRISMA guidelines.
    Xiao Z; Liang R; Wang CQ; Xu S; Li N; He Y; Tang F; Chen L; Ma H
    Medicine (Baltimore); 2016 Aug; 95(35):e4517. PubMed ID: 27583861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.